HNSBF - Hansa Biopharma sees 2025 growth through expanded IDEFIRIX adoption and new market reimbursements February, 06 2025 01:13 PM Hansa Biopharma AB 2025-02-06 13:13:33 ET More on Hansa Biopharma Hansa Biopharma AB (HNSBF) Q4 2024 Earnings Call Transcript Historical earnings data for Hansa Biopharma Financial information for Hansa Biopharma For further details see: Hansa Biopharma sees 2025 growth through expanded IDEFIRIX adoption and new market reimbursements